Quirónsalud Torrevieja signs a collaboration agreement with AFECANCER
The Hospital Quirónsalud de Torrevieja has signed an agreement with the Association of Relatives and Patients with Cancer of Torrevieja (AFECÁNCER) in order to collaborate in different activities and especially with patients undergoing some type of treatment as a result of a cancer diagnosis.
Among the different benefits offered to the associates, there is free access to group therapy offered by the Hospital Quironsalud Torrevieja, aimed at patients who have cancer or have overcome it and their families, as well as very advantageous discounts on nutritional packages for patients with chemotherapy and radiotherapy treatment, consultations and diagnostic tests.
The Association of Relatives and Patients with Cancer of Torrevieja (AFECÁNCER), is an entity formed by people who have had a direct relationship with the cancer disease and who wish to invest their effort in helping, altruistically, those who currently suffer from it , in order to protect and promote the rights of sick people, trying to undertake all those actions aimed at increasing their well-being and quality of life.
Current events
Current events
- 14 de octubre de 2025
Los pacientes con obesidad operados en el Hospital público Universitario General de Villalba pierden...
Gracias a un programa integral con cirugía mínimamente invasiva y seguimiento multidisciplinarHospital Universitario General de Villalbaen/health-centers/hospital-universitario-general-villalba - 15 de octubre de 2025
Hospital Universitari Dexeus, sede de un programa de ejercicio físico para pacientes con cáncer ginecológico
La iniciativa, impulsada por la Fundación IOR con el apoyo de GSK, busca mejorar la tolerancia a los tratamientos, reducir efectos secundarios y aumentar la calidad de vida d...Hospital Universitari Dexeusen/health-centers/hospital-universitari-dexeusOncología Médicaen/specialities/oncologia-medica - 14 de octubre de 2025
El Hospital Universitari General de Catalunya lidera el uso de radioterapia a bajas dosis en patologías...
El pasado 9 de octubre, el Dr. J. Pardo Masferrer, del Servicio de Oncología Radioterápica del Hospital Universitari General de Catalunya, presentó ante sus colegas los resu...Hospital Universitari General de Catalunyaen/health-centers/hospital-universitari-general-catalunyaOncología Radioterápicaen/specialities/oncologia-radioterapica